Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, R. W.
NEUROLOGY 1995;45:S70-S72
© 1995 American Academy of Neurology

The future of predictors, prevention, and therapy in postherpetic neuralgia

Robert W. Johnson, MB, BS, FRCA

From the Pain Management Clinic, Bristol Royal Infirmary, England.
Address correspondence and reprint requests to Dr. Robert W. Johnson, Consultant Anaesthetist and Director, Pain Management Clinic, Bristol Royal Infirmary, Bristol BS2 8HW, England.

Pain is the most common complication of herpes zoster, but much confusion and dissent exist regarding terminology.Established (chronic) herpetic pain is remarkably resistant to treatment, but its prevention is partly achievable. Prodromal and acute herpetic pain are predictors for chronic pain. If research programs and clinical management are to progress optimally, researchers and clinicians must agree on appropriate use of such terms as "zoster-associated pain'' and "postherpetic neuralgia.''

NEUROLOGY 1995;45(Suppl 8): S70-S72






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by AAN Enterprises, Inc.